Works about HEPATITIS C diagnosis

Results: 1128
    1
    2
    3
    4

    The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real‐life experience.

    Published in:
    Liver International, 2018, v. 38, n. 4, p. 733, doi. 10.1111/liv.13588
    By:
    • the ITACOPS study group;
    • Martini, Silvia;
    • Carrai, Paola;
    • Donato, Maria Francesca;
    • Mazzarelli, Chiara;
    • Rendina, Maria;
    • Visco‐Comandini, Ubaldo;
    • Filì, Daniela;
    • Gianstefani, Alice;
    • Caraceni, Paolo;
    • Fagiuoli, Stefano;
    • Melazzini, Mario;
    • Montilla, Simona;
    • Pani, Luca;
    • Petraglia, Sandra;
    • Russo, Pierluigi;
    • Trotta, Maria Paola
    Publication type:
    Article
    5

    Real‐world efficacy and safety of ombitasvir, paritaprevir/r+dasabuvir+ribavirin in genotype 1b patients with hepatitis C virus cirrhosis.

    Published in:
    Liver International, 2018, v. 38, n. 4, p. 602, doi. 10.1111/liv.13550
    By:
    • Preda, Carmen M.;
    • Manuc, Mircea;
    • Gheorghe, Liana;
    • Proca, Doina;
    • Constantinescu, Ileana;
    • Diculescu, Mircea M.;
    • Oproiu, Alexandru;
    • Popescu, Corneliu P.;
    • Ceausu, Emanoil;
    • Ruta, Simona M.;
    • Baicus, Cristian;
    • Voiosu, Theodor A.;
    • Pop, Corina Silvia;
    • Sporea, Ioan;
    • Trifan, Anca;
    • Tantau, Marcel;
    • Tantau, Alina
    Publication type:
    Article
    6
    7

    The impact of hepatitis C virus outside the liver: Evidence from Asia.

    Published in:
    Liver International, 2017, v. 37, n. 2, p. 159, doi. 10.1111/liv.13272
    By:
    • Younossi, Zobair M.;
    • Tanaka, Atsushi;
    • Eguchi, Yuichiro;
    • Lim, Young ‐ Suk;
    • Yu, Ming ‐ Lung;
    • Kawada, Norifumi;
    • Dan, Yock Young;
    • Brooks ‐ Rooney, Craig;
    • Negro, Francesco;
    • Mondelli, Mario U.
    Publication type:
    Article
    8
    9
    10
    11

    Apolipoprotein E allele frequencies in chronic and self-limited hepatitis C suggest a protective effect of APOE4 in the course of hepatitis C virus infection.

    Published in:
    Liver International, 2016, v. 36, n. 9, p. 1267, doi. 10.1111/liv.13094
    By:
    • Mueller, Tobias;
    • Fischer, Janett;
    • Gessner, Reinhard;
    • Rosendahl, Jonas;
    • Böhm, Stephan;
    • Bömmel, Florian;
    • Knop, Viola;
    • Sarrazin, Christoph;
    • Witt, Heiko;
    • Marques, Andreas Mas;
    • Kovacs, Peter;
    • Schleinitz, Dorit;
    • Stumvoll, Michael;
    • Blüher, Matthias;
    • Bugert, Peter;
    • Schott, Eckart;
    • Berg, Thomas
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Pangenotypic triple versus double therapy in HCV-infected patients after prior failure of direct-acting antivirals.

    Published in:
    Clinical & Experimental Hepatology, 2023, v. 9, n. 3, p. 193, doi. 10.5114/ceh.2023.130935
    By:
    • Flisiak, Robert;
    • Zarębska-Michaluk, Dorota;
    • Berak, Hanna;
    • Dybowska, Dorota;
    • Sitko, Marek;
    • Parfieniuk-Kowerda, Anna;
    • Janocha-Litwin, Justyna;
    • Janczewska, Ewa;
    • Piekarska, Anna;
    • Lorenc, Beata;
    • Mazur, Włodzimierz;
    • Dobrowolska, Krystyna;
    • Tudrujek-Zdunek, Magdalena;
    • Klapaczyński, Jakub;
    • Jaroszewicz, Jerzy
    Publication type:
    Article
    48
    49
    50